Related Experiment Video
Updated: Sep 4, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Natriuretic peptides, extracellular volume, and subclinical cardiovascular changes in chronic kidney disease stages
L Parker Gregg1,2,3, Peter N Van Buren4,5, David J Ramsey3
1Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA lucile.gregg@bcm.edu.
Insights
Elevated natriuretic peptides in early chronic kidney disease (CKD) stages 1-3 correlate with cardiovascular changes, not fluid overload. These biomarkers may detect subclinical heart issues in CKD patients.
Area of Science:
- Nephrology
- Cardiology
- Biomarkers
Background:
- Natriuretic peptide levels are elevated in early chronic kidney disease (CKD) stages 1-3.
- The association with extracellular volume excess or early cardiovascular changes is unclear.
Purpose of the Study:
- To investigate cardiovascular changes in patients with CKD stages 1-3.
- To determine if these changes correlate with brain natriuretic peptide (BNP) and amino-terminal-pro-BNP (NT-pro-BNP) levels and patient-reported symptoms.
Main Methods:
- Compared cardiovascular parameters (extracellular water, total peripheral resistance index, cardiac index) in CKD stages 1-3 patients and non-CKD controls.
- Utilized whole-body multifrequency bioimpedance spectroscopy and impedance cardiography.
- Assessed patient-reported symptoms using questionnaires.
Main Results:
- CKD patients exhibited higher pulse pressure and total peripheral resistance index, with a lower cardiac index compared to controls.
- Natriuretic peptides correlated with pulse pressure, cardiac index, and total peripheral resistance index, but not extracellular water.
- Total peripheral resistance index and blood pressure showed moderate correlation with patient symptoms.
Conclusions:
- Elevated natriuretic peptides in early CKD may indicate subclinical cardiovascular changes like low cardiac index and elevated peripheral resistance.
- Further research is needed to explore the role of these biomarkers in detecting early cardiovascular alterations in CKD.
Abstract:
Natriuretic peptide levels are elevated in persons with chronic kidney disease (CKD) stages 1-3, but it remains unclear whether this is associated with extracellular volume excess or early cardiovascular changes. We hypothesized that patients with CKD stages 1-3 would have evidence of cardiovascular changes, which would associate with brain natriuretic peptide (BNP), amino-terminal-pro-BNP (NT-pro-BNP), and patient-reported symptoms.Outpatients with CKD stages 1-3 and non-CKD controls were enrolled. Cardiovascular parameters included extracellular water (ECW) normalized to body weight measured using whole-body multifrequency bioimpedance spectroscopy, and total peripheral resistance index (TPRI) and cardiac index measured by impedance cardiography. Dyspnea, fatigue, depression, and quality of life were quantified using questionnaires.Among 21 participants (13 with CKD), median (IQR) BNP was 47.0 (28.0-302.5) vs 19.0 (12.3-92.3) pg/mL, p=0.07, and NT-pro-BNP was 245.0 (52.0-976.8) vs 26.0 (14.5-225.8) pg/mL, p=0.08, in the CKD and control groups, respectively. Those with CKD had higher pulse pressure (79 (66-87) vs 64 (49-67) mm Hg, p=0.046) and TPRI (3721 (3283-4278) vs 2933 (2745-3198) dyn×s/cm5/m2, p=0.01) and lower cardiac index (2.28 (2.08-2.78) vs 3.08 (2.43-3.37) L/min/m2, p=0.02). In the overall cohort, natriuretic peptides correlated with pulse pressure (BNP r=0.59; NT-pro-BNP r=0.58), cardiac index (BNP r=-0.76; NT-pro-BNP r=-0.62), and TPRI (BNP r=0.48), p<0.05 for each, but not with ECW/weight. TPRI and blood pressure correlated moderately with symptoms.Elevated natriuretic peptides may coincide with low cardiac index and elevated peripheral resistance in patients with CKD stages 1-3. The role of these biomarkers to detect subclinical cardiovascular changes needs to be further explored.
Related Concept Videos
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure II: Pathophysiology
Chronic Kidney Disease I: Introduction

